Literature DB >> 19871459

THE CARDIOTOXIC ACTION OF PREPARATIONS CONTAINING THE OXYGEN-LABILE HEMOLYSIN OF STREPTOCOCCUS PYOGENES : II. INHIBITION OF CARDIOTOXIC EFFECT BY A SUBSTANCE RELEASED FROM THE FROG'S HEART.

G L Cantoni1, A W Bernheimer.   

Abstract

1. The mechanism of sensitization of the isolated frog' heart to a product of the hemolytic streptococcus has been investigated. The sensitization depends upon the release from the isolated heart of a substance which inhibits the action of the cardiotoxin. The inhibitor is released upon the first (sensitizing) administration of cardiotoxin, but not upon the second (contracture-producing) administration. 2. The inhibitor released by the heart neutralizes the lethal factor present in the streptococcal preparation employed. 3. Some of the properties of the inhibitor have been investigated.

Entities:  

Year:  1945        PMID: 19871459      PMCID: PMC2135491          DOI: 10.1084/jem.81.3.307

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  2 in total

1.  A Lethal Agent Produced by the Hemolytic Streptococcus.

Authors:  T N Harris
Journal:  J Bacteriol       Date:  1942-06       Impact factor: 3.490

2.  THE CARDIOTOXIC ACTION OF PREPARATIONS CONTAINING THE OXYGEN-LABILE HEMOLYSIN OF STREPTOCOCCUS PYOGENES : I. INCREASED SENSITIVITY OF THE ISOLATED FROG'S HEART TO REPEATED APPLICATION OF THE TOXIN.

Authors:  A W Bernheimer; G L Cantoni
Journal:  J Exp Med       Date:  1945-03-01       Impact factor: 14.307

  2 in total
  2 in total

1.  Loss of myocardial contractility induced in isolated mammalian hearts by streptolysin O.

Authors:  A W BERNHEIMER; A S CARLSON; E B FREEMAN; A KELLNER
Journal:  J Exp Med       Date:  1956-09-01       Impact factor: 14.307

2.  THE TOXIC ACTION OF PREPARATIONS CONTAINING THE OXYGEN-LABILE HEMOLYSIN OF STREPTOCOCCUS PYOGENES : III. INDUCTION IN MICE OF TEMPORARY RESISTANCE TO THE LETHAL EFFECT OF THE TOXIN.

Authors:  A W Bernheimer; G L Cantoni
Journal:  J Exp Med       Date:  1947-08-31       Impact factor: 14.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.